Expert Opinion on Biological Therapy, Volume 23, Issue 5 (2023)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Biological Therapy, Volume 23, Issue 5 (2023)

See all volumes and issues
Vol 24, 2024 Volume 23, 2023 Vol 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Drug Evaluation

Article
Nivolumab + relatlimab for the treatment of unresectable or metastatic melanoma
Hanna Koseła-Paterczyk & Piotr Rutkowski
Pages: 383-388
Published online: 24 May 2023
AbstractforNivolumab + relatlimab for the treatment of unresectable or metastatic melanoma | Full Text | References | PDF (266.6 KB) | EPUB
  • 155 Views
  • 0 CrossRef citations
  • 0Altmetric

Perspective

Article
Interferon lambda as a potential treatment for COVID-19
Matthew W McCarthy
Pages: 389-394
Published online: 08 May 2023
AbstractforInterferon lambda as a potential treatment for COVID-19 | Full Text | References | PDF (237.8 KB) | EPUB
  • 127 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Review Article
Monoclonal antibodies for treatment of cold agglutinin disease
Georg Gelbenegger, Sigbjørn Berentsen & Bernd Jilma
Pages: 395-406
Published online: 15 May 2023
AbstractforMonoclonal antibodies for treatment of cold agglutinin disease | Full Text | References | PDF (1 MB) | EPUB
  • 343 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
Clinical utility of checkpoint inhibitors against metastatic bladder cancer: overcoming challenges to find a way forward
Andreia Bilé-Silva, Antonio Lopez-Beltran, Ana Blanca, Fernando Lopez-Rios, Enrique Gómez-Gómez, Alessia Cimadamore, Rodolfo Montironi, Nuno Vau & Liang Cheng
Pages: 407-418
Published online: 10 Apr 2023
AbstractforClinical utility of checkpoint inhibitors against metastatic bladder cancer: overcoming challenges to find a way forward | Full Text | References | PDF (443.3 KB) | EPUB
  • 114 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Emerging role of monoclonal antibodies in the treatment of IgA nephropathy
Dita Maixnerova & Vladimir Tesar
Pages: 419-427
Published online: 18 May 2023
AbstractforEmerging role of monoclonal antibodies in the treatment of IgA nephropathy | Full Text | References | PDF (2.9 MB) | EPUB
  • 606 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Anti-IL17 treatment in childhood chronic rheumatic diseases
Valerio Maniscalco, Ilaria Maccora, Flavio Girodo, Marta Tomaselli, Gaia Priolo, Edoardo Marrani, Maria Vincenza Mastrolia, Ilaria Pagnini & Gabriele Simonini
Pages: 429-441
Published online: 19 May 2023
AbstractforAnti-IL17 treatment in childhood chronic rheumatic diseases | Full Text | References | PDF (1.5 MB) | EPUB
  • 377 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Research

Article
REcovery and SURvival of patients with moderate to severe acute REspiratory distress syndrome (ARDS) due to COVID-19: a multicenter, single-arm, Phase IV itolizumab Trial: RESURRECT
Raveendra KR, Chirag Rathod, Rahul Darnule, Subramanian Loganathan, Sarika Deodhar, Radhika A, Ashwani Marwah, Nitin M Chaudhari, Binay K Thakur, Sivakumar Vaidyanathan & Sandeep Nilkanth Athalye
Pages: 443-454
Published online: 28 Apr 2023
AbstractforREcovery and SURvival of patients with moderate to severe acute REspiratory distress syndrome (ARDS) due to COVID-19: a multicenter, single-arm, Phase IV itolizumab Trial: RESURRECT | Full Text | References | PDF (1.8 MB) | EPUB | Supplemental
  • 126 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles